CRO
CONTRACT RESEARCH ORGANIZATION
Read articles about the roles of CROs (Contract Research Organizations) in bringing new drugs, therapies, and assays to market.
Antibiotic-Resistant Gonorrhea: A Growing Global Crisis
At any given time, one in five people in the US has a sexually transmitted infection (STI), translating to more than 68 million infections.1 These infections cost billions in healthcare expenses each year. Even more alarming, over 48% of all new STIs in this country...
Inside Influenza Reverse Genetics: Engineering Recombinant Viruses for Safer Research
Influenza viruses exist in many forms, with varying levels of pathogenicity. One well-known example is avian influenza, which ranges from low-pathogenic (LPAI) to highly pathogenic (HPAI) strains. Highly pathogenic strains are essential for understanding emerging...
The Zodiac, Reimagined Through Microbiology
Lab Week is a time to recognize the people who keep science moving forward every day. From routine quality control to complex problem solving, laboratory professionals bring focus, resilience, and a deep sense of purpose to their work. They also bring something less...
Tuberculosis Research: Why M. tuberculosis Remains One of the World’s Most Resilient Pathogens
Despite decades of research and treatment options, tuberculosis (TB) remains one of the world’s most devastating infectious diseases, claiming more than one million lives each year and continuing to challenge global public health efforts.1, 2, 3 Drug resistance,...
Delivering Confidence: How Inactivation, Quality Processes, and Documentation Ensure Reliable Viral Materials
Choosing a virology services provider is often framed around tangible transactional capabilities, virus stock inventory, assay panel availability, or specialized techniques. But experienced service teams know that technical execution is only as strong as the quality...
The Unique Challenges of Quality Control for Live Biotherapeutic Products
Live Biotherapeutic Products (LBPs) are drug products designed to prevent, treat, or cure disease using living microorganisms. These therapeutics present unique challenges for quality control, especially in the development of microbial safety methods. This blog post...
The Critical Role of Genomic Sequencing in Ensuring Integrity of Viral Stocks
In vaccine and antiviral development, confidence in viral identity and genome integrity is essential. Whether confirming strain authenticity, validating genetic modifications, or identifying spontaneous mutations, genomics analyses ensure that research materials align...
From Gut to Clinic: How Microbiome Science is Powering the Next Generation of Therapies
They outnumber your human cells. They influence everything from digestion to immunity. And now, microbes are reshaping how we understand and treat disease. The microbiome, the vast community of microorganisms living in and on our bodies, plays a crucial role in...
Inside Microbiologics’ Global Virology Center: How Custom Viral Stocks Power Vaccine and Antiviral Breakthroughs
In the world of vaccine and antiviral development, access to high-quality, reliable viral reference materials can make or break a research program. Yet, few outside the industry understand how these critical reagents are manufactured, or by whom. When most people...
Ensuring Biopharmaceutical Safety: Integrating Viral Safety and Mycoplasma Testing
Adventitious agent testing is critical to ensure patient safety and maintain product integrity. Biopharmaceuticals, often derived from living cells, are susceptible to contamination by viruses and mycoplasmas, which can be introduced during cell culture, raw material...
